Effect of Cabergoline on biochemical and anthropometric parameters of patient with Impaired Glucose metabolism (Impaired Fasting Glucose/Impaired Glucose Tolerance)

This study tests whether a medication called cabergoline can help people with pre-diabetes — blood sugar levels that are higher than normal but not yet high enough to be called diabetes — avoid developing full type 2 diabetes. Pre-diabetes usually has no treatment besides lifestyle changes, but many people still progress to diabetes. Cabergoline works on the brain's dopamine system and may help improve blood sugar, insulin sensitivity, and other metabolic measurements. Researchers will track body weight, blood sugar levels, and other health markers over the course of the study. You may be eligible if: - You are between 20 and 65 years old - You have been told your blood sugar is in the pre-diabetes range (fasting glucose 100–110 mg/dL, or 2-hour glucose after a glucose tolerance test between 140–199 mg/dL) - You are male or female You may NOT be eligible if: - You have serious liver disease - You have fibrotic disorders affecting the lungs, heart valves, or abdomen - You are allergic to ergot-derived medications - You have uncontrolled high blood pressure - You have diabetes (not just pre-diabetes) - You are pregnant or breastfeeding - You have a major psychiatric disorder or an eating disorder (bulimia or anorexia) Talk to your doctor about whether this trial might be right for you.